Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aster DM Quality CareNSE:ASTERDM -0.16%74 3-Year EPS without NRI Growth Rate is 54.10% as of Jun. 2026, which is 1324% above its 10-year median of 3.80. GuruFocus rates NSE:ASTERDM with a GF Score™ of 74/100 and a GF Value™ of ₹643.06 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 502 Healthcare Providers & Services companies, Aster DM Quality Care ranks better than 88.84% on this metric.
During the past 12 months, Aster DM Quality Care's average EPS without NRI Growth Rate was 2.10% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 54.10% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 11.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 12 years, the highest 3-Year average EPS without NRI Growth Rate of Aster DM Quality Care was 54.10% per year. The lowest was -28.10% per year. And the median was 3.80% per year.
Aster DM Quality Care (NSE:ASTERDM) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Aster DM Quality Care 3-Year EPS without NRI Growth Rate Related Terms
NSE:ASTERDM vs HCA, THC, EHC: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, Aster DM Quality Care's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aster DM Quality Care 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Aster DM Quality Care's 3-Year EPS without NRI Growth Rate falls into.
Aster DM Quality Care 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 54.10% mean?
Aster DM Quality Care (NSE:ASTERDM) has a 3-Year EPS without NRI Growth Rate of 54.10% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Aster DM Quality Care and its competitors. This is 1324% above median its historical median of 3.80. According to the industry distribution chart, Aster DM Quality Care ranks #56 out of 502 companies in the Healthcare Providers & Services industry, placing it in the top 11.2%.
Is Aster DM Quality Care's 3-Year EPS without NRI Growth Rate too high?
Aster DM Quality Care's current 3-Year EPS without NRI Growth Rate of 54.10% is 1324% above median its 10-year median of 3.80. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 10.70. Aster DM Quality Care's value of 54.10% is 405.6% above this industry median. Based on the distribution chart, Aster DM Quality Care ranks #56 out of 502 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Aster DM Quality Care has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's 3-Year EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aster DM Quality Care ranks #56 out of 502 companies for 3-Year EPS without NRI Growth Rate. This places Aster DM Quality Care in the top 11% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 10.70. Aster DM Quality Care's value of 54.10% is 405.6% above this benchmark. While the company's 10-year median is 3.80 vs. the industry median of 10.70, Aster DM Quality Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 10.70, based on 502 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aster DM Quality Care's current 3-Year EPS without NRI Growth Rate of 54.10% is 405.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Aster DM Quality Care and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 10.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aster DM Quality Care's current 3-Year EPS without NRI Growth Rate is 54.10%, which is 1324% above median its own 10-year median of 3.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹643.06, compared to a current price of ₹795.65 — trading 23.7% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 54.10%, which is 1324% above median its 10-year median of 3.80 and 405.6% above the Healthcare Providers & Services industry median of 10.70. Aster DM Quality Care's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current 3-Year EPS without NRI Growth Rate is 54.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?
Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued.
The current stock price of ₹795.65 is trading 23.7% above its estimated GF Value™ of ₹643.06.
GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.
Key valuation signals for NSE:ASTERDM:
3-Year EPS without NRI Growth Rate: 54.10% (1324% above median its 10-year median of 3.80)
GF Value™: ₹643.06 vs. price of ₹795.65 (23.7% above fair value)
Industry Position: 405.6% above the Healthcare Providers & Services median (#56 of 502)
No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
74GF Score
Get the complete analysis for NSE:ASTERDM
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTERDM has been successfully added to your 
